Not every lump on a newborn’s neck is a reason to panic. However, if doctors detect an unusual growth in this area, it may be a cervical teratoma. Although the term can sound alarming, understanding what it means — and how doctors classify these tumours- can help families manage the diagnosis with confidence.

Histological classification involves examining tumour tissue under a microscope. This allows specialists to identify the different types of cells and tissues inside the growth. Cervical teratomas can contain tissues such as bone, muscle, cartilage, or skin. By studying whether these tissues are mature (well-developed) or immature (less developed or more aggressive), doctors can better predict how the tumour will behave, what treatment is required, and what outcome to expect.

What are cervical teratomas?

A cervical teratoma is a tumour that develops in or around a newborn’s neck. The word “cervical” comes from the Latin term for “neck”. These tumours originate from pluripotent germ cells — early embryonic cells capable of developing into any type of body tissue.

During early development, an embryo forms from three germ layers:

• Ectoderm: forms the skin and nervous system
• Mesoderm: develops into muscles, bones, blood vessels, and cartilage
• Endoderm: gives rise to internal organs, including the lungs and digestive tract

Because pluripotent germ cells can turn into any of these tissue types, teratomas often contain a mixture of different tissues — such as hair, bone, cartilage, muscle, or even nervous tissue — within a single tumour.

Cervical teratomas are rare, occurring in about 1 in 35,000 to 80,000 live births.¹ Most are detected during routine prenatal ultrasound scans or soon after birth, when a noticeable neck mass becomes visible. Large tumours can make it difficult for newborns to breathe or swallow, requiring urgent medical attention.²

Characteristics of mature cervical teratomas

Histological features

About 90–95% of all cervical teratomas are mature, making them the most common type.³ Under the microscope, they contain well-organised, fully developed tissues — miniature, normal-looking versions of skin, muscle, or bone found elsewhere in the body.

Clinical behaviour and prognosis

Mature cervical teratomas tend to grow slowly and do not invade nearby tissues or spread to other parts of the body.⁴ Complete surgical removal usually leads to full recovery, with very low recurrence rates and a five-year survival rate approaching 100%.⁵

However, the initial situation can still be critical, particularly if the tumour compresses the airway or affects feeding soon after birth.⁶ Careful surgical planning and neonatal intensive care support are key to ensuring safety during and after treatment.

Characteristics of immature cervical teratomas

Histological features

Immature cervical teratomas are less common but more concerning. Under a microscope, these tumours contain primitive or underdeveloped cells, most often resembling immature nerve, cartilage, or bone tissue.⁷

Pathologists classify these tumours into Grades 1–3, based on how much immature tissue is present. The higher the grade, the greater the proportion of primitive cells — and the higher the likelihood of aggressive behaviour or recurrence.⁷

Clinical behaviour and prognosis

Immature teratomas can grow quickly and, in some cases, spread to other parts of the body.⁸ The prognosis depends on how immature the cells are:

• Grade 1 tumours usually behave in a low-risk, less aggressive way
• Grades 2–3 may require surgery plus chemotherapy⁸

The five-year survival rate ranges from 70–90%, depending on the tumour’s grade and how completely it was removed.⁹

How doctors diagnose and classify cervical teratomas

Histological examination

Diagnosis begins once the tumour is surgically removed. The pathologist first examines the specimen by eye, then prepares thin slices for microscopic study using special stains (usually haematoxylin and eosin). This allows assessment of the tissue structure and the presence of mature or immature elements.

Imaging studies

Before and after birth, ultrasound, CT, and MRI scans provide key diagnostic information.²

• Prenatal ultrasound often detects cervical teratomas while the baby is still in the womb
• CT or MRI scans help define the size, exact position, and effect on surrounding structures such as the airway or major blood vessels

Certain imaging signs — such as bright white areas (indicating bone or teeth), fatty tissue, or fluid pockets — can suggest a teratoma. Still, only microscopic tissue analysis after removal can confirm whether the tumour is mature or immature.

Treatment implications based on classification

Management of mature teratomas

The main treatment is complete surgical removal. The surgical team plans carefully to avoid injury to vital structures in the neck, such as the windpipe and blood vessels.⁴ Once the tumour is removed, only routine follow-up is needed. Regular physical examinations and occasional imaging confirm that the tumour has not returned — although recurrence is extremely rare.

Management of immature teratomas

Immature teratomas often require a multidisciplinary approach. Surgery remains the first step, but chemotherapy may follow for higher-grade cases to destroy any remaining cancerous cells.⁷˒⁸ These treatments have been shown to reduce recurrence risk and improve long-term outcomes.⁹

Children with immature teratomas need long-term follow-up, including imaging, tumour marker blood tests, and developmental monitoring.

Advances and future directions

Recent research in molecular biology has provided deeper insight into how teratomas form. Specific genetic markers and chromosomal changes may help predict tumour behaviour and treatment response in future.¹⁰

Improved neonatal anaesthesia and surgical techniques have already made operations safer for newborns. For high-grade immature tumours, scientists are now exploring modified chemotherapy regimens designed to remain effective while minimising side effects.¹¹

Summary

Cervical teratomas are rare tumours that appear in a newborn’s neck. The most important step in diagnosis is histological classification, which determines whether the tumour is mature or immature.

• Mature teratomas are benign, have an excellent prognosis, and are usually cured with surgery
• Immature teratomas may behave more aggressively, requiring additional treatments such as chemotherapy

Early diagnosis through prenatal imaging, skilled surgical management, and accurate histological assessment are key to ensuring good outcomes. Continued research into the genetic and molecular characteristics of these tumours is helping doctors refine treatment strategies and improve survival for affected infants.

FAQs

Is there a genetic cause for cervical teratomas?

Currently, there is no strong genetic link. Most cases occur randomly and are not inherited. Having one child with a cervical teratoma does not increase the risk in future pregnancies.

Can infants die from cervical teratomas?

Yes, though this is rare. Large tumours can block the airway and cause life-threatening breathing difficulties immediately after birth. Prompt diagnosis and surgical planning are crucial to prevent this.

How common are fatal cases?

Reports suggest mortality rates of 9–15%, mostly due to airway obstruction in the first few days of life. Early detection and coordinated delivery planning have greatly improved survival rates.

Can cervical teratomas be predicted during pregnancy?

Not genetically. However, they can often be detected on a routine prenatal ultrasound, typically between 18–22 weeks of pregnancy. In some cases, doctors may request a foetal MRI for detailed evaluation.

Can the tumour be removed before birth?

At present, fetal surgery for cervical teratomas is not routinely performed due to high risks. Instead, planned delivery in a specialist centre with neonatal surgical expertise provides the safest approach.

Are cervical teratomas cancerous?

Mature teratomas are non-cancerous (benign). Immature teratomas contain rapidly dividing cells that behave more aggressively and may require chemotherapy after surgery.